Delivery Order SPE2DB22D2206-SPE2DB26FDS45
Award Date 10/20/25
Potential Completion Date 11/10/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 mL unit doses totaling 20,000 units. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, utilizes firm fixed pricing under a non-competitive delivery order structure. This order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) in 1,200-600 mg formulations totaling 30,000 units of 15 ml each. This is a firm fixed-price delivery order with a ceiling value of $8,225.29 and a completion date of September 15, 2025. The order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 ml units, totaling 20,000 units with delivery completion by October 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a $8,225.29 delivery order to AmerisourceBergen Drug Corp for PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk), a specialty pharmaceutical product used in cancer treatment. The delivery order, issued on August 6, 2025, calls for 30,000 units of the 1,200-600 mg/15mL formulation with an ultimate completion date of August 27, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product in 10 milliliter units, with a total order quantity of 20,000 units valued at $10,916.78. The contract is issued as a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $32,750.34 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with an ultimate completion date of October 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a $10,916.78 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10 mL vials. This is an unset-aside, competitively awarded contract with a completion date of June 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...